10.26188/5bffd9504464a
ADA CHEUNG
ADA
CHEUNG
CHRISTOPHER CUNNINGHAM
CHRISTOPHER
CUNNINGHAM
DONG-KYOON KO
DONG-KYOON
KO
Vivian Ly
Vivian
Ly
HANS GRAY
HANS
GRAY
Rudolf Hoermann
Rudolf
Hoermann
Boyd Strauss
Boyd
Strauss
EBRAHIM BANI HASSAN
EBRAHIM
BANI HASSAN
GUSTAVO DUQUE
GUSTAVO
DUQUE
PETER EBELING
PETER
EBELING
MARCUS PANDY
MARCUS
PANDY
JEFFREY ZAJAC
JEFFREY
ZAJAC
MATHIS GROSSMANN
MATHIS
GROSSMANN
Supplementary Figures.docx
The University of Melbourne
2018
muscle mass loss
muscle forces
androgen suppression
Androgen Deprivation Therapy
Prostate Cancer Cells Prostate cancer
Medicine
Endocrinology
Motor Control
2018-11-29 12:20:04
Figure
https://melbourne.figshare.com/articles/figure/Supplementary_Figures_docx/7398761
Supplementary Figures for Manuscript Titled "Selective loss of levator ani and leg muscle volumes in men undergoing androgen deprivation therapy." This is data from a case-control study comparing men newly commencing ADT and prostate cancer controls followed from baseline to 12 months. The primary outcome was muscle function outcomes. Supplementary Figure 1 shows the relationship between levator ani muscle volume change (x axis) and change in other androgen-sensitive parameters (y – axis i.e. hemoglobin, hematocrit, sexual function, fat mass and lean mass) from 12 to 0 months as a percentage forming an xy point each. Supplementary Figure 2 is a plot of pairs of muscle function change (y-axis) and muscle volume change (x-axis) from 12 to 0 months as a percentage forming an xy point each.